Normal perioperative serum calcitonin levels in patients with advanced medullary thyroid carcinoma: Case report and review of the literature

Thyroid

Volumn 18, Issue 8, 2008, Pages 895-899

  Dora, José Miguel ^a   Da Silva Canalli, Maria Heloisa Busi ^a   Capp, Clarissa ^a   Puñales, Márcia Khaled ^a   Vieira, José Gilberto H ^a   Maia, Ana Luiza ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN;

ADULT; ADVANCED CANCER; ARTICLE; CALCITONIN BLOOD LEVEL; CASE REPORT; CASE STUDY; CHEMOLUMINESCENCE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN PROCESSING; THYROID MEDULLARY CARCINOMA;

ADULT; CALCITONIN; CARCINOMA, MEDULLARY; HUMANS; MALE; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 50649100154     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2007.0231     Document Type: Article

References (26)

1. You YN, Lakhani V, Wells SA Jr., Moley JF 2006 Medullary thyroid cancer. Surg Oncol Clin N Am 15:639-660.
2. Papi G, Corsello SM, Cioni K, Pizzini AM, Corrado S, Carapezzi C, Fadda G, Baldini A, Carani C, Pontecorvi A, Roti E 2006 Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: a multicenter study. J Endocrinol Invest 29:427-437.
3. Vierhapper H, Niederle B, Bieglmayer C, Kaserer K, Baumgartner-Parzer S 2005 Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid 15:1267-1272.
4. Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M, Filetti S 2007 Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 92:450-455.
5. Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Di Coscio G, Miccoli P, Pinchera A 1994 Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 78:826-829.
6. Rieu M, Lame MC, Richard A, Lissak B, Sambort B, Vuong-Ngoc P, Berrod JL, Fombeur JP 1995 Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules. Clin Endocrinol (Oxf ) 42:453-460.
7. Niccoli P, Wion-Barbot N, Caron P, Henry JF, de Micco C, Saint Andre JP, Bigorgne JC, Modigliani E, Conte-Devolx B 1997 Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group. J Clin Endocrinol Metab 82:338-341.
8. Cohen R, Campos JM, Salaun C, Heshmati HM, Kraimps JL, Proye C, Sarfati E, Henry JF, Niccoli-Sire P, Modigliani E 2000 Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC). J Clin Endocrinol Metab 85:919-922.
9. Iacobone M, Niccoli-Sire P, Sebag F, de Micco C, Henry JF 2002 Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels. World J Surg 26:886-890.
10. Machens A, Schneyer U, Holzhausen HJ, Dralle H 2005 Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level. J Clin Endocrinol Metab 90:2029-2034.
11. Leboeuf R, Langlois MF, Martin M, Ahnadi CE, Fink GD 2006 "Hook effect" in calcitonin immunoradiometric assay in patients with metastatic medullary thyroid carcinoma: case report and review of the literature. J Clin Endocrinol Metab 91:361-364.
12. de Bondt RB, Nelemans PJ, Hofman PA, Casselman JW, Kremer B, van Engelshoven JM, Beets-Tan RG 2007 Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging. Eur J Radiol 64:266-272.
13. Gourgiotis L, Sarlis NJ, Reynolds JC, VanWaes C, Merino MJ, Pacak K 2003 Localization of medullary thyroid carcinoma metastasis in a multiple endocrine neoplasia type 2A patient by 6-[18F]-fluorodopamine positron emission tomography. J Clin Endocrinol Metab 88:637-641.
14. Boi F, Maurelli I, Pinna G, Atzeni F, Piga M, Lai ML, Mariotti S 2007 Calcitonin measurement in wash-out fluid from fine needle aspiration of neck masses in patients with primary and metastatic medullary thyroid carcinoma. J Clin Endocrinol Metab 92:2115-2118.
15. Sand M, Gelos M, Sand D, Bechara FG, Bonhag G, Welsing E, Mann B 2006 Serum calcitonin negative medullary thyroid carcinoma. World J Surg Oncol 4:97.
16. Iglesias P, Vicandi B, Ortega P, Diez PP 1997 [Anaplastic variant of thyroid medullar carcinoma]. Med Clín (Barc) 109:276-277.
17. Diez JJ, Iglesias P 2004 Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma. Thyroid 14:984-985.
18. Letelier C, Pineda P, Rodriguez F, Carreño L, Jaimovich L, Massardo T 2007 Cancer medular de tiroides mestastatico con niveles plasmaticos de calcitonina indetectables, caso clinico. Abstract Book of the Latin American Thyroid Society XII Congress:162.
19. Lips CJ, Landsvater RM, Hoppener JW, Geerdink RA, Blijham G, van Veen JM, van Gils AP, de Wit MJ, Zewald RA, Berends MJ, Beemer FA, Brouwers-Smalbraak J, Jansen R, van Amstel HK, van Vroonhoven T, Vroom TM 1994 Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N Engl J Med 331:828-835.
20. Machens A, Ukkat J, Brauckhoff M, Gimm O, Dralle H 2005 Advances in the management of hereditary medullary thyroid cancer. J Intern Med 257:50-59.
21. Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, Miccoli P, Iacconi P, Basolo F, Pinchera A, Pacini F 2004 Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 89:163-168.
22. Vierhapper H, Raber W, Bieglmayer C, Kaserer K, Weinhausl A, Niederle B 1997 Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab 82:1589-1593.
23. Ozgen AG, Hamulu F, Bayraktar F, Yilmaz C, Tuzun M, Yetkin E, Tuncyurek M, Kabalak T 1999 Evaluation of routine basal serum calcitonin measurement for early diagnosis of medullary thyroid carcinoma in seven hundred seventy-three patients with nodular goiter. Thyroid 9:579-582.
24. Bugalho MJ, Santos JR, Sobrinho L 2005 Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin measurement. J Surg Oncol 91:56-60.
25. Redding AH, Levine SN, Fowler MR 2000 Normal preoperative calcitonin levels do not always exclude medullary thyroid carcinoma in patients with large palpable thyroid masses. Thyroid 10:919-922.
26. Bockhorn M, Frilling A, Rewerk S, Liedke M, Dirsch O, Schmid KW, Broelsch CE 2004 Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma. Thyroid 14:468-470.